ANL logo

Accretion Nutraveda Ltd

ANL·BSE·
276.00 +0.00 (+0.00%)
Market Cap199.82 Cr
PE Ratio5.38
Volume1,000
Day High - Low276.00 - 276.00
52W High-Low313.00 - 150.10
DocStoX Score
6.8/10
Fair
Fair Value
Sign in to see
ROE
25.00%
Strong
P/E
5.38x
Cheap
Debt / Equity
0.12
Low
Industry
Healthcare
Pharmaceuticals
Overall View
Fair

Price performance

52W150.10
313.00
DocStoX take

Supported by growth (8.5) and momentum (7.5), but weakest on valuation (5.0).

DocStoX score

Low confidence
6.8
/10
Fair
Quality
Solid
ROE 25.0%
Valuation
Fair
P/E 5.4×
Growth
Strong
Revenue +126.8% 3Y CAGR
Risk
Moderate
D/E 0.12
Momentum
Strong
77% of 52-week range

At a glance

Market Cap
₹200 Cr
52W High / Low
₹313 / ₹150
Dividend Yield
0.00%
Promoter Holding
73.48%
EPS (TTM)
₹51.33
Book Value
₹49.00

Key highlights

  • Profit compounding 163% a year
  • Revenue compounding 127% a year
  • Capital works hard — ROCE 58%
  • Small ₹200 cr company — thinner liquidity
4 Positives1 Watchout

Growth

Financials

Shareholding

Technicals

Peers

News

Forecasts

About the company

More data

Filings, corporate actions and ownership detail — opened on demand.

More Healthcare stocks · Pharmaceuticals

Accretion Nutraveda Ltd peers in Healthcare

Other Healthcare stocks on the NSE & BSE. See the full Healthcare sector list.